Found: 11
Select item for more details and to access through your institution.
Metopimazine is primarily metabolized by a liver amidase in humans.
- Published in:
- Pharmacology Research & Perspectives, 2022, v. 10, n. 1, p. 1, doi. 10.1002/prp2.903
- By:
- Publication type:
- Article
Metopimazine is primarily metabolized by a liver amidase in humans.
- Published in:
- Pharmacology Research & Perspectives, 2022, v. 10, n. 2, p. 1, doi. 10.1002/prp2.903
- By:
- Publication type:
- Article
MK2-induced tristetraprolin:14-3-3 complexes prevent stress granule association and ARE-mRNA decay.
- Published in:
- EMBO Journal, 2004, v. 23, n. 6, p. 1313, doi. 10.1038/sj.emboj.7600163
- By:
- Publication type:
- Article
TIA-1 is a translational silencer that selectively regulates the expression of TNF-a.
- Published in:
- EMBO Journal, 2000, v. 19, n. 15, p. 4154, doi. 10.1093/emboj/19.15.4154
- By:
- Publication type:
- Article
Low over-expression of TNFα in the mouse heart increases contractile performance via TNFR1.
- Published in:
- Journal of Cellular Biochemistry, 2008, v. 105, n. 1, p. 99, doi. 10.1002/jcb.21798
- By:
- Publication type:
- Article
STRATUS: A Phase II Study of Abituzumab in Patients With Systemic Sclerosis-associated Interstitial Lung Disease.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Ongoing clinical trials and treatment options for patients with systemic sclerosis–associated interstitial lung disease.
- Published in:
- Rheumatology, 2019, v. 58, n. 4, p. 567, doi. 10.1093/rheumatology/key151
- By:
- Publication type:
- Article
Effect of Intra-Articular Sprifermin vs Placebo on Femorotibial Joint Cartilage Thickness in Patients With Osteoarthritis: The FORWARD Randomized Clinical Trial.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Efficacy and Safety of Atacicept in Patients With Systemic Lupus Erythematosus.
- Published in:
- Arthritis & Rheumatology, 2018, v. 70, n. 2, p. 266, doi. 10.1002/art.40360
- By:
- Publication type:
- Article
Post Hoc Analysis of the Phase II/III APRIL-SLE Study: Association Between Response to Atacicept and Serum Biomarkers Including BLyS and APRIL.
- Published in:
- Arthritis & Rheumatology, 2017, v. 69, n. 1, p. 122, doi. 10.1002/art.39809
- By:
- Publication type:
- Article
Obexelimab in Systemic Lupus Erythematosus With Exploration of Response Based on Gene Pathway Co‐Expression Patterns: A Double‐Blind, Randomized, Placebo‐Controlled, Phase 2 Trial.
- Published in:
- Arthritis & Rheumatology, 2023, v. 75, n. 12, p. 2185, doi. 10.1002/art.42652
- By:
- Publication type:
- Article